Cencora Inc.

COR · NYSE · Healthcare / Medical Distribution

359.03USD+9.65 (+2.76%)

Price History

Full chart

Market Stats

Previous Close349.38

Open351.12

Day Range350.11 – 359.39

52-Week Range243.78 – 375.33

Volume1.39M

Market Cap63.16B

P/E (TTM)24.57

Forward P/E15.55

EPS13.47

Dividend Yield0.73%

Beta0.58

50-Day Avg322.04

200-Day Avg317.43

About

Cencora, Inc. sources and distributes pharmaceutical products in the United States and internationally. The company's U.S. Healthcare Solutions segment distributes generic and injectable pharmaceuticals, over-the-counter healthcare products, home healthcare supplies and equipment, and related services to acute care hospitals and health systems, independent and chain retail pharmacies, mail order pharmacies, medical clinics, long-term care and alternate site pharmacies, and other customers; distributes plasma and other blood products, vaccines, and other specialty pharmaceutical products; provides pharmacy management, staffing, and other consulting services; supply management software to retail and institutional healthcare providers; packaging solutions to institutional and retail healthcare providers; clinical trial support, product post-approval, and commercialization support services; data analytics, outcomes research, and other services for biotechnology and pharmaceutical manufacturers; pharmaceuticals, vaccines, parasiticides, diagnostics, micro feed ingredients, and other products to the companion animal and production animal markets; sales force services to manufacturers; and offers other services to physicians who specialize in various disease states, such as oncology, as well as to other healthcare providers, including hospitals and dialysis clinics. Its International Healthcare Solutions segment provides international pharmaceutical wholesale and related service, and global commercialization services; distributes pharmaceuticals, other healthcare products, and related services to pharmacies, doctors, health centers, and hospitals; and offers specialty transportation and logistics services for the biopharmaceutical industry. The company was formerly known as AmerisourceBergen Corporation and changed its name to Cencora, Inc. in August 2023. Cencora, Inc. was founded in 1871 and is headquartered in Conshohocken, Pennsylvania.

Company Details

SectorHealthcare
IndustryMedical Distribution
CEODr. Robert P. Mauch Ph.D., PharmD
Employees47.00K
Headquarters1 West First Avenue, Conshohocken, PA, United States, 19428-1800, USA
Websitehttps://www.cencora.com

Leadership

Dr. Robert P. Mauch Ph.D., PharmDPresident, CEO & Director · b. 1967
Ms. Elizabeth S. Campbell J.D.Executive VP & Chief Legal Officer · b. 1975
Mr. James F. Cleary Jr.Advisor · b. 1963
Ms. Silvana BattagliaAdvisor · b. 1968
Ms. Eva C. BorattoExecutive VP & CFO · b. 1967
Mr. Lazarus KrikorianSenior VP, Chief Accounting Officer & Corporate Controller · b. 1965
Mr. Pawan Singh VermaExecutive VP and Chief Data & Information Officer · b. 1977
Mr. Bennett S. MurphySenior VP Of Investor Relations & Enterprise Productivity and Treasury
Ms. Samantha L. HammockExecutive VP & Chief Human Resources Officer · b. 1979
Mr. Richard TremonteEVP and President of U.S. Pharmaceuticals & Animal Health

Financials

Income Statement

Currency: USD	1994-09-30	1995-09-30	1996-09-30	1997-09-30	1998-09-30	1999-09-30	2000-09-30	2001-09-30	2002-09-30	2003-09-30	2004-09-30	2005-09-30	2006-09-30	2007-09-30	2008-09-30	2009-09-30	2010-09-30	2011-09-30	2012-09-30	2013-09-30	2014-09-30	2015-09-30	2016-09-30	2017-09-30	2018-09-30	2019-09-30	2020-09-30	2021-09-30	2022-09-30	2023-09-30	2024-09-30	2025-09-30

Currency: USD	1994-09-30	1995-09-30	1996-09-30	1997-09-30	1998-09-30	1999-09-30	2000-09-30	2001-09-30	2002-09-30	2003-09-30	2004-09-30	2005-09-30	2006-09-30	2007-09-30	2008-09-30	2009-09-30	2010-09-30	2011-09-30	2012-09-30	2013-09-30	2014-09-30	2015-09-30	2016-09-30	2017-09-30	2018-09-30	2019-09-30	2020-09-30	2021-09-30	2022-09-30	2023-09-30	2024-09-30	2025-09-30
Total Revenue	4.30B	4.67B	5.55B	7.82B	8.67B	9.81B	11.65B	16.19B	45.23B	49.66B	53.18B	54.58B	61.20B	66.07B	70.19B	71.76B	77.95B	80.22B	79.49B	87.96B	119.57B	135.96B	146.85B	153.14B	167.94B	179.59B	189.89B	213.99B	238.59B	262.17B	293.96B	321.33B
Growth (%)	-	+8.53%	+18.91%	+40.78%	+10.91%	+13.13%	+18.74%	+39.04%	+179.38%	+9.78%	+7.09%	+2.63%	+12.14%	+7.96%	+6.23%	+2.24%	+8.63%	+2.90%	-0.91%	+10.65%	+35.94%	+13.71%	+8.01%	+4.29%	+9.66%	+6.94%	+5.74%	+12.69%	+11.50%	+9.89%	+12.12%	+9.31%
Cost of Revenue	4.06B	4.40B	5.25B	7.43B	8.25B	9.33B	11.12B	15.49B	43.21B	47.41B	51.07B	52.72B	59.10B	63.87B	68.24B	69.74B	75.70B	77.79B	76.98B	85.64B	116.80B	132.75B	143.08B	149.00B	163.83B	175.06B	185.10B	207.72B	230.99B	254.42B	285.26B	311.19B
Gross Profit	243.30M	268.80M	304.90M	389.30M	423.10M	475.60M	520.89M	700.12M	2.02B	2.25B	2.06B	1.86B	2.10B	2.20B	1.95B	2.02B	2.25B	2.43B	2.51B	2.32B	2.77B	3.22B	3.77B	4.15B	4.11B	4.53B	4.79B	6.27B	7.60B	7.76B	8.70B	10.14B
Gross Margin	5.66%	5.76%	5.49%	4.98%	4.88%	4.85%	4.47%	4.32%	4.48%	4.53%	3.86%	3.41%	3.44%	3.33%	2.78%	2.81%	2.89%	3.03%	3.16%	2.64%	2.32%	2.36%	2.57%	2.71%	2.45%	2.52%	2.52%	2.93%	3.19%	2.96%	2.96%	3.16%
Operating Expense	165.40M	171.00M	207.00M	269.70M	271.50M	301.70M	320.46M	440.74M	1.31B	1.36B	1.18B	1.23B	1.38B	1.41B	1.12B	1.12B	1.16B	1.20B	1.23B	1.33B	1.59B	1.91B	2.09B	2.13B	2.46B	2.66B	2.77B	3.59B	4.85B	5.31B	5.66B	6.49B
Operating Income	77.90M	97.80M	97.90M	119.60M	151.60M	173.90M	200.43M	259.38M	718.43M	883.11M	870.48M	624.83M	727.93M	786.61M	823.54M	899.13M	1.09B	1.23B	1.28B	989.02M	1.19B	1.31B	1.68B	2.02B	1.65B	1.87B	2.02B	2.68B	2.75B	2.45B	3.04B	3.65B
Operating Margin	1.81%	2.09%	1.76%	1.53%	1.75%	1.77%	1.72%	1.60%	1.59%	1.78%	1.64%	1.14%	1.19%	1.19%	1.17%	1.25%	1.40%	1.53%	1.61%	1.12%	0.99%	0.96%	1.15%	1.32%	0.98%	1.04%	1.07%	1.25%	1.15%	0.93%	1.03%	1.14%
EBITDA	272.40M	107.90M	109.50M	133.90M	194.90M	208.70M	216.73M	307.59M	833.49M	967.77M	970.69M	616.93M	850.03M	965.10M	932.32M	977.61M	1.20B	1.33B	1.40B	1.07B	939.18M	630.59M	1.92B	1.49B	1.87B	1.65B	-4.73B	2.92B	3.12B	3.42B	3.37B	3.75B
EBITDA Margin	6.33%	2.31%	1.97%	1.71%	2.25%	2.13%	1.86%	1.90%	1.84%	1.95%	1.83%	1.13%	1.39%	1.46%	1.33%	1.36%	1.54%	1.66%	1.76%	1.21%	0.79%	0.46%	1.31%	0.97%	1.11%	0.92%	-2.49%	1.36%	1.31%	1.30%	1.15%	1.17%
Net Income	-207.70M	10.20M	35.50M	45.40M	50.50M	67.50M	99.01M	125.10M	344.94M	441.23M	468.39M	319.20M	467.71M	469.17M	250.56M	503.40M	636.75M	706.62M	718.99M	433.71M	276.48M	-134.89M	1.43B	414.48M	1.66B	855.37M	-3.40B	1.54B	1.70B	1.75B	1.51B	1.55B
Net Income Margin	-4.83%	0.22%	0.64%	0.58%	0.58%	0.69%	0.85%	0.77%	0.76%	0.89%	0.88%	0.58%	0.76%	0.71%	0.36%	0.70%	0.82%	0.88%	0.90%	0.49%	0.23%	-0.10%	0.97%	0.27%	0.99%	0.48%	-1.79%	0.72%	0.71%	0.67%	0.51%	0.48%
Interest Expense	-	-	-	-	-	-	-	-	140.73M	-	112.70M	57.22M	12.46M	75.71M	75.10M	63.50M	74.81M	78.90M	97.22M	75.05M	77.70M	112.02M	144.35M	149.04M	189.64M	195.47M	158.52M	182.54M	231.98M	275.65M	248.68M	419.75M
Interest Expense % of Total Revenue	-	-	-	-	-	-	-	-	0.31%	-	0.21%	0.10%	0.02%	0.11%	0.11%	0.09%	0.10%	0.10%	0.12%	0.09%	0.06%	0.08%	0.10%	0.10%	0.11%	0.11%	0.08%	0.09%	0.10%	0.11%	0.08%	0.13%

Balance Sheet

Currency: USD	1994-09-30	1995-09-30	1996-09-30	1997-09-30	1998-09-30	1999-09-30	2000-09-30	2001-09-30	2002-09-30	2003-09-30	2004-09-30	2005-09-30	2006-09-30	2007-09-30	2008-09-30	2009-09-30	2010-09-30	2011-09-30	2012-09-30	2013-09-30	2014-09-30	2015-09-30	2016-09-30	2017-09-30	2018-09-30	2019-09-30	2020-09-30	2021-09-30	2022-09-30	2023-09-30	2024-09-30	2025-09-30

Currency: USD	1994-09-30	1995-09-30	1996-09-30	1997-09-30	1998-09-30	1999-09-30	2000-09-30	2001-09-30	2002-09-30	2003-09-30	2004-09-30	2005-09-30	2006-09-30	2007-09-30	2008-09-30	2009-09-30	2010-09-30	2011-09-30	2012-09-30	2013-09-30	2014-09-30	2015-09-30	2016-09-30	2017-09-30	2018-09-30	2019-09-30	2020-09-30	2021-09-30	2022-09-30	2023-09-30	2024-09-30	2025-09-30
Total Assets	711.60M	838.70M	1.19B	1.75B	1.55B	2.06B	2.46B	10.29B	11.21B	12.04B	11.65B	11.38B	12.78B	12.31B	12.22B	13.57B	14.43B	14.98B	15.44B	18.92B	21.53B	27.74B	33.59B	35.32B	37.67B	39.17B	44.27B	57.34B	56.56B	62.56B	67.10B	76.59B
Total Liabilities	1.01B	974.40M	1.22B	1.73B	1.48B	1.89B	2.18B	7.45B	7.90B	8.03B	7.31B	7.10B	8.64B	9.21B	9.51B	10.86B	11.48B	12.12B	12.99B	16.60B	19.58B	27.35B	31.51B	33.25B	34.97B	36.47B	45.11B	56.75B	56.49B	61.89B	66.31B	74.84B
Total Equity	-300.70M	-135.70M	-36.80M	14.30M	75.30M	166.30M	282.29M	2.84B	3.32B	4.01B	4.34B	4.28B	4.14B	3.10B	2.71B	2.72B	2.95B	2.87B	2.46B	2.32B	1.96B	616.39M	2.13B	2.06B	2.93B	2.88B	-1.02B	223.35M	-211.56M	522.00M	645.94M	1.51B
Cash	25.30M	32.20M	65.60M	60.00M	48.50M	59.50M	120.82M	297.63M	663.34M	800.04M	871.34M	966.55M	1.26B	640.20M	878.11M	1.01B	1.66B	1.83B	1.07B	1.23B	1.81B	2.17B	2.74B	2.44B	2.49B	3.37B	4.60B	2.55B	3.53B	2.69B	3.23B	4.39B
Total Debt	487.70M	435.80M	433.70M	589.80M	453.80M	558.70M	413.22M	1.60B	1.82B	1.78B	1.44B	952.71M	1.10B	1.23B	1.19B	1.18B	1.34B	1.36B	1.45B	1.40B	2.00B	3.74B	4.46B	3.79B	4.66B	4.49B	4.98B	8.75B	7.59B	6.82B	6.65B	10.75B
Net Debt	462.40M	403.60M	368.10M	529.80M	405.30M	499.20M	292.40M	1.30B	1.15B	984.12M	567.13M	-13.84M	-165.78M	587.57M	311.02M	168.63M	-314.60M	-461.04M	380.16M	165.60M	187.12M	1.57B	1.72B	1.36B	2.17B	1.12B	385.38M	6.20B	4.06B	4.13B	3.42B	6.35B

Cash Flow

Currency: USD	1994-09-30	1995-09-30	1996-09-30	1997-09-30	1998-09-30	1999-09-30	2000-09-30	2001-09-30	2002-09-30	2003-09-30	2004-09-30	2005-09-30	2006-09-30	2007-09-30	2008-09-30	2009-09-30	2010-09-30	2011-09-30	2012-09-30	2013-09-30	2014-09-30	2015-09-30	2016-09-30	2017-09-30	2018-09-30	2019-09-30	2020-09-30	2021-09-30	2022-09-30	2023-09-30	2024-09-30	2025-09-30

Currency: USD	1994-09-30	1995-09-30	1996-09-30	1997-09-30	1998-09-30	1999-09-30	2000-09-30	2001-09-30	2002-09-30	2003-09-30	2004-09-30	2005-09-30	2006-09-30	2007-09-30	2008-09-30	2009-09-30	2010-09-30	2011-09-30	2012-09-30	2013-09-30	2014-09-30	2015-09-30	2016-09-30	2017-09-30	2018-09-30	2019-09-30	2020-09-30	2021-09-30	2022-09-30	2023-09-30	2024-09-30	2025-09-30
Operating Cash Flow	84.00M	-35.60M	40.00M	-9.30M	125.90M	3.00M	216.58M	-40.00M	535.93M	354.81M	825.08M	1.53B	807.26M	1.21B	737.07M	783.76M	1.11B	1.17B	1.31B	788.13M	1.46B	3.92B	3.18B	1.49B	1.41B	2.34B	2.21B	2.67B	2.70B	3.91B	3.48B	3.88B
Investing Cash Flow	-8.00M	-16.30M	-44.60M	-144.90M	-8.10M	-16.80M	-21.49M	117.49M	-202.81M	-201.81M	-242.22M	-152.31M	-42.70M	-674.44M	163.42M	-148.35M	-184.37M	-212.42M	-947.95M	117.26M	-384.15M	-2.93B	-3.17B	-498.04M	-1.11B	-375.83M	-379.87M	-6.14B	-368.44M	-2.60B	-618.10M	-4.98B
Financing Cash Flow	-77.80M	58.80M	38.10M	148.70M	-129.40M	24.80M	-133.77M	99.32M	32.60M	-16.31M	-511.55M	-929.99M	-469.85M	-1.15B	-662.58M	-504.16M	-275.44M	-787.72M	-1.12B	-740.99M	-501.49M	-630.28M	565.07M	-1.31B	-242.87M	-1.09B	-603.62M	1.95B	-1.75B	-2.22B	-2.33B	2.25B
Capital Expenditure	8.50M	13.70M	15.70M	15.90M	10.40M	15.80M	16.62M	23.36M	64.16M	90.55M	189.28M	203.38M	113.13M	118.05M	137.31M	145.84M	184.63M	167.95M	164.04M	202.45M	264.46M	231.59M	464.62M	466.40M	336.41M	310.22M	369.68M	438.22M	496.32M	458.36M	487.17M	667.98M
Free Cash Flow	75.50M	-49.30M	24.30M	-25.20M	115.50M	-12.80M	199.96M	-63.37M	471.77M	264.26M	635.80M	1.32B	694.13M	1.09B	599.76M	637.93M	923.99M	999.99M	1.14B	585.67M	1.20B	3.69B	2.71B	1.02B	1.07B	2.03B	1.84B	2.23B	2.21B	3.45B	3.00B	3.21B
Dividends Paid	-	-	-	-	-	-	-	-	10.50M	10.99M	11.20M	10.60M	20.59M	37.25M	48.67M	62.70M	90.62M	117.62M	132.76M	195.72M	214.47M	253.92M	288.48M	320.27M	333.04M	338.97M	343.58M	366.65M	391.69M	398.75M	416.17M	437.08M
FCF to OCF	89.88%	138.48%	60.75%	270.97%	91.74%	-426.67%	92.33%	158.40%	88.03%	74.48%	77.06%	86.68%	85.99%	90.23%	81.37%	81.39%	83.35%	85.62%	87.43%	74.31%	81.93%	94.09%	85.38%	68.68%	76.16%	86.77%	83.25%	83.57%	81.64%	88.28%	86.02%	82.76%
Dividend Paid to FCF	-	-	-	-	-	-	-	-	2.23%	4.16%	1.76%	0.80%	2.97%	3.42%	8.12%	9.83%	9.81%	11.76%	11.63%	33.42%	17.89%	6.88%	10.63%	31.32%	30.98%	16.67%	18.70%	16.45%	17.75%	11.55%	13.88%	13.63%

Earnings

Report Date	Dec 31, 1997	Mar 31, 1998	Jun 30, 1998	Sep 30, 1998	Dec 31, 1998	Mar 31, 1999	Jun 30, 1999	Sep 30, 1999	Jan 27, 2000	Apr 27, 2000	Jul 27, 2000	Nov 1, 2000	Feb 1, 2001	Apr 26, 2001	Jul 25, 2001	Nov 8, 2001	Jan 24, 2002	Apr 25, 2002	Jul 31, 2002	Nov 5, 2002	Jan 24, 2003	Apr 24, 2003	Jul 24, 2003	Nov 5, 2003	Jan 26, 2004	Apr 26, 2004	Jul 22, 2004	Nov 2, 2004	Jan 25, 2005	Apr 21, 2005	Jul 21, 2005	Nov 3, 2005	Jan 25, 2006	Apr 26, 2006	Jul 25, 2006	Nov 2, 2006	Jan 24, 2007	Apr 25, 2007	Jul 26, 2007	Nov 1, 2007	Jan 24, 2008	Apr 23, 2008	Jul 24, 2008	Oct 30, 2008	Jan 22, 2009	Apr 23, 2009	Jul 30, 2009	Nov 3, 2009	Jan 26, 2010	Apr 22, 2010	Jul 27, 2010	Nov 2, 2010	Feb 4, 2011	Apr 28, 2011	Jul 28, 2011	Nov 1, 2011	Jan 26, 2012	Apr 26, 2012	Jul 26, 2012	Nov 1, 2012	Jan 24, 2013	Apr 25, 2013	Jul 24, 2013	Oct 31, 2013	Jan 23, 2014	Apr 24, 2014	Jul 24, 2014	Oct 30, 2014	Jan 28, 2015	Apr 30, 2015	Jul 23, 2015	Oct 29, 2015	Feb 4, 2016	May 5, 2016	Aug 2, 2016	Nov 2, 2016	Jan 31, 2017	May 4, 2017	Aug 3, 2017	Nov 2, 2017	Feb 6, 2018	May 2, 2018	Aug 2, 2018	Nov 6, 2018	Jan 31, 2019	May 2, 2019	Aug 1, 2019	Nov 7, 2019	Jan 30, 2020	May 7, 2020	Aug 5, 2020	Nov 5, 2020	Feb 4, 2021	May 5, 2021	Aug 4, 2021	Nov 4, 2021	Feb 2, 2022	May 4, 2022	Aug 3, 2022	Nov 3, 2022	Feb 1, 2023	May 2, 2023	Aug 2, 2023	Nov 2, 2023	Jan 31, 2024	May 1, 2024	Jul 31, 2024	Nov 6, 2024	Feb 5, 2025	May 7, 2025	Aug 6, 2025	Nov 5, 2025	Feb 4, 2026	May 6, 2026	Aug 5, 2026	Nov 4, 2026
EPS Estimate	-	-	-	-	-	-	-	-	-	-	-	0.13	0.12	0.14	0.14	0.16	0.16	0.18	0.20	0.21	0.20	0.26	0.26	0.26	0.24	0.30	0.25	0.19	0.16	0.20	0.21	0.23	0.20	0.27	0.27	0.28	0.28	0.34	0.31	0.32	0.31	0.38	0.33	0.35	0.35	0.45	0.39	0.40	0.46	0.55	0.49	0.48	0.54	0.69	0.59	0.56	0.63	0.81	0.69	0.68	0.67	0.88	0.75	0.74	0.78	0.99	0.92	1.05	0.97	1.19	1.15	1.18	1.25	1.58	1.27	1.23	1.23	1.68	1.37	1.32	1.35	1.82	1.45	1.46	1.51	1.96	1.62	1.58	1.67	2.27	1.59	1.87	1.94	2.46	2.04	2.36	2.58	2.92	2.56	2.57	2.63	3.30	2.83	2.81	2.89	3.69	3.22	3.22	3.52	4.10	3.84	3.79	4.04	4.73	4.37	4.52
EPS Actual	0.08	0.08	0.08	0.02	0.09	0.10	0.10	0.04	0.10	0.12	0.12	0.13	0.12	0.14	0.14	0.16	0.17	0.22	0.22	0.22	0.21	0.26	0.26	0.26	0.24	0.31	0.26	0.21	0.15	0.20	0.23	0.24	0.22	0.28	0.28	0.31	0.33	0.34	0.30	0.35	0.31	0.41	0.37	0.37	0.37	0.48	0.42	0.44	0.52	0.63	0.52	0.50	0.57	0.77	0.66	0.61	0.62	0.83	0.72	0.69	0.69	0.88	0.73	0.79	0.80	1.06	1.01	1.10	1.14	1.45	1.20	1.17	1.27	1.68	1.37	1.30	1.36	1.77	1.43	1.33	1.55	1.94	1.54	1.45	1.60	2.11	1.76	1.61	1.76	2.40	1.85	1.89	2.18	2.53	2.16	2.39	2.58	3.22	2.62	2.60	2.71	3.50	2.92	2.86	3.28	3.80	3.34	3.34	3.73	4.42	4.00	3.84	4.08	4.75	4.48	-
Surprise	-	-	-	-	-	-	-	-	-	-	-	0.00%	0.00%	0.00%	0.00%	0.00%	6.25%	22.22%	10.00%	4.76%	5.00%	0.00%	0.00%	0.00%	0.00%	3.33%	4.00%	10.53%	-6.25%	0.00%	9.52%	4.35%	10.00%	3.70%	3.70%	10.71%	17.86%	0.00%	-3.23%	9.38%	0.00%	7.89%	12.12%	5.71%	5.71%	6.67%	7.69%	10.00%	13.04%	14.55%	6.12%	4.17%	5.56%	11.59%	11.86%	8.93%	-1.59%	2.47%	4.35%	1.47%	2.99%	0.00%	-2.67%	6.76%	2.56%	7.07%	9.78%	4.76%	17.53%	21.85%	4.35%	-0.85%	1.60%	6.33%	7.87%	5.69%	10.57%	5.36%	4.38%	0.76%	14.81%	6.59%	6.21%	-0.68%	5.96%	7.65%	8.64%	1.90%	5.39%	5.73%	16.35%	1.07%	12.37%	2.85%	5.88%	1.27%	0.00%	10.27%	2.34%	1.17%	3.04%	6.06%	3.18%	1.78%	13.49%	2.98%	3.73%	3.73%	5.97%	7.80%	4.17%	1.32%	0.99%	0.42%	2.52%	-
Timing	-	-	-	-	-	-	-	-	-	-	-	Pre-market	Pre-market	Pre-market	Pre-market	Pre-market	Pre-market	Pre-market	Pre-market	Pre-market	Pre-market	Pre-market	Pre-market	Pre-market	Pre-market	Pre-market	Pre-market	Pre-market	Pre-market	Pre-market	Pre-market	Pre-market	Pre-market	Pre-market	Pre-market	Pre-market	Pre-market	Pre-market	Pre-market	Pre-market	Pre-market	Pre-market	Pre-market	Pre-market	Pre-market	Pre-market	Pre-market	Pre-market	Pre-market	Pre-market	Pre-market	Pre-market	Pre-market	Pre-market	Pre-market	Pre-market	Pre-market	Pre-market	Pre-market	Pre-market	Pre-market	Pre-market	Pre-market	Pre-market	Pre-market	Pre-market	Pre-market	Pre-market	Pre-market	Pre-market	Pre-market	Pre-market	Pre-market	Pre-market	Pre-market	Pre-market	Pre-market	Pre-market	Pre-market	Pre-market	Pre-market	Pre-market	Pre-market	Pre-market	Pre-market	Pre-market	Pre-market	Pre-market	Pre-market	Pre-market	Pre-market	Pre-market	Pre-market	Pre-market	Pre-market	Pre-market	Pre-market	Pre-market	Pre-market	Pre-market	Pre-market	Pre-market	Pre-market	Pre-market	Pre-market	Pre-market	Pre-market	-	Pre-market	Pre-market	Pre-market	Pre-market	Pre-market	Pre-market	Pre-market	Pre-market

Key Statistics & Ratios

Market Cap63.16B

Enterprise Value67.95B

Trailing P/E24.57

Forward P/E15.55

PEG Ratio0.65

Price / Sales0.19

Price / Book19.35

EPS13.47

Book Value15.99

Revenue (TTM)332.77B

Gross Profit (TTM)13.18B

EBITDA5.55B

Profit Margin0.79%

Operating Margin1.41%

Return on Equity96.87%

Return on Assets3.56%

Shares Outstanding190.83M

Shares Float180.25M

Beta0.58

Dividend Yield0.73%

Dividend Rate2.40

Payout Ratio13.99%

Analyst Ratings

Buy

Based on 14 analystsTarget 369.08

Strong Buy
7
Buy
3
Hold
4

Ownership Breakdown

Institutions: 99.36%
Insiders: 4.30%
Retail / Other: 0.00%

Top Institutional Holders

BlackRock Inc
18.21M9.54%
Vanguard Capital Management, LLC
12.38M6.49%
Vanguard Portfolio Management, LLC
9.61M5.04%
State Street Corp
9.27M4.86%
T. Rowe Price Investment Management,Inc.
7.41M3.88%
T. Rowe Price Associates, Inc.
7.13M3.74%
JPMorgan Chase & Co
5.94M3.11%
Geode Capital Management, LLC
5.45M2.86%
Boston Partners Global Investors, Inc
4.87M2.55%
Wellington Management Company LLP
4.56M2.39%
FMR Inc
4.12M2.16%
Morgan Stanley - Brokerage Accounts
4.09M2.14%
Bank of America Corp
3.73M1.96%

Top Fund Holders

Vanguard MStar Total Stk Mkt Idx Invest
5.75M3.01%
Vanguard 500 Index Investor
5.01M2.63%
T. Rowe Price Capital Appreciation
3.90M2.04%
Vanguard MStar Mid Cap Index Instl
3.88M2.03%
Vanguard Health Care Inv
2.84M1.49%
iShares Core S&P 500 ETF
2.54M1.33%
Fidelity 500 Index
2.53M1.32%

Dividends

20264×

0.66Nov 13, 20260.60Aug 14, 20260.60May 15, 20260.60Feb 13, 2026

20254×

0.60Nov 14, 20250.55Aug 15, 20250.55May 16, 20250.55Feb 14, 2025

20244×

0.55Nov 15, 20240.51Aug 9, 20240.51May 9, 20240.51Feb 8, 2024

20234×

0.51Nov 10, 20230.48Aug 10, 20230.48May 11, 20230.48Feb 9, 2023

20224×

0.48Nov 10, 20220.46Aug 12, 20220.46May 13, 20220.46Feb 11, 2022

20214×

1.27Dec 1, 20210.46Nov 12, 20211.27Sep 29, 20210.44Aug 13, 2021

Stock Splits

Jun 16, 20092:1
Dec 29, 20052:1
Mar 25, 19992:1